Your First Step Toward Renewed Hope
Spravato Therapy
At StrongTower Behavioral Healthcare, we are proud to offer Spravato (esketamine) therapy, a groundbreaking treatment for individuals struggling with treatment-resistant depression (TRD) and other mood disorders. If traditional antidepressant medications have not provided relief, Spravato therapy may be the solution you’ve been searching for.
What to Expect During Your Spravato Treatment
At StrongTower Behavioral Healthcare, we ensure a safe and comfortable experience during your Spravato treatments. The therapy is administered in- office under the supervision of our trained psychiatric team. You’ll be closely monitored for at least two hours after each treatment to ensure your safety and well-being. Most treatments are scheduled twice a week initially, with adjustments made as needed based on your progress.
Is Spravato Therapy Right for You?
If you are struggling with treatment-resistant depression or have not found relief from traditional medications, Spravato therapy might be an effective option. Our compassionate psychiatrists at StrongTower Behavioral Healthcare are here to help you explore the potential benefits of Spravato and determine if it’s the right treatment for you.
Benefits of Spravato Therapy
Rapid Onset of Relief
Unlike traditional antidepressants that may take weeks to show results, many patients experience symptom relief within hours or days.
Non-Invasive Treatment
Administered as a nasal spray in a controlled office setting, Spravato does not require intravenous injections or oral medication.
Effective for Treatment-Resistant Depression
Spravato is specifically designed to help those whose depression has not improved with other medications.
Improved Quality of Life
By helping to alleviate symptoms of depression more quickly, Spravato therapy can improve overall well-being and restore a sense of hope for many patients.
Frequently Asked Questions About Spravato
SPRAVATO® (esketamine) CIII nasal spray is a derivative of ketamine. SPRAVATO® is an FDA-approved nasal spray for treatment-resistant depression; it is also approved to treat depressive symptoms in adults with major depressive disorder with suicidal thoughts or actions. Ketamine has not been approved by the FDA to treat depression. Both SPRAVATO® and ketamine are Schedule III controlled substances under the US Controlled Substances Act.
Most major insurances (Aetna, Cigna, Horizon, United, Medicare, Medicaid) cover SPRAVATO™ treatments. Additionally, various support programs from Janssen Pharmaceuticals help patients cover the costs of medication and of administration/observation.
No, administered at small doses in a medical setting, there is no evidence that Spravato is addictive (study). In contrast, those who abuse this medication recreationally do so at very high doses to induce psycho-active affects.
You cannot take SPRAVATO® on your own. You will administer SPRAVATO® nasal spray yourself under the supervision of a healthcare provider, at a certified SPRAVATO® treatment center. You can choose the location that works best for you; ask your healthcare provider to help find a location. SPRAVATO® cannot be purchased at a pharmacy. Because of the risks for sedation or loss of consciousness, dissociation, respiratory depression, and abuse and misuse, SPRAVATO® can only be administered at healthcare settings certified in the SPRAVATO® Risk Evaluation and Mitigation Strategy (REMS) Program.
Do NOT take SPRAVATO® if any of the following applies to you:
You are allergic to esketamine, a similar medicine called ketamine used for anesthesia, or any of the other ingredients in SPRAVATO®.
You have a blood vessel disease (aneurysm), an abnormal connection between your blood vessels (arteriovenous malformation) or a history of bleeding in the brain.
At each visit, your healthcare provider(s) will ask about your symptoms of depression, side effects and whether or not you are experiencing noticeable improvement. In the clinical studies of SPRAVATO®, a standardized scale called the Montgomery-Åsberg Depression Rating Scale was used to track treatment-resistant depression symptoms and response to treatment.
It’s a good idea to ask your healthcare provider(s) at the start of SPRAVATO® treatment how they will be evaluating your response to treatment, and what you can do to help with that. If your referring healthcare provider is not the same provider treating you with SPRAVATO®, you should ask when, and in what way, your new healthcare provider will be letting your referring provider know how your treatments are going and how you are doing.
Contact Us for Spravato Therapy
Take the first step toward a brighter future by reaching out to our team to learn more about Spravato therapy and how it can help you manage treatment-resistant depression. We’re here to support you every step of the way on your mental health journey.
Start Your Journey Toward Healing with Spravato Therapy
At StrongTower Behavioral Healthcare, we are committed to helping you find the most effective treatments for your mental health. If you are interested in learning more about Spravato therapy or want to schedule a consultation with one of our expert mental health providers, contact us today.
